Matches 1 - 50 out of 141 1 2 3 >


Match Document Document Title
US20110118189 NOVEL FORMULATIONS FOR TREATMENT OF MIGRAINE  
Systems and methods are described for treating un-met medical needs in migraine and related conditions such as cluster headache. Included are treatments that are both rapid onset and long acting,...
US20130197023 NEUROPROTECTION BY PHARMACOLOGICAL CHAPERONING OF NICOTINIC ACETYLCHOLINE RECEPTORS  
A method of ameliorating an endoplasmic reticulum (ER) stress response and/or unfolded protein response (UPR) in cells expressing nicotinic acetylcholine receptors (nAChRs) comprises contacting a...
US20130345230 METHODS AND COMPOSITIONS FOR MODULATING CALCIUM CHANNELS  
The present invention relates to methods and compositions for modulating calcium channels. In particular, the present invention provides methods and compositions for modulating (e.g., disrupting)...
US20120264808 METHODS AND COMPOSITIONS FOR MODULATING CALCIUM CHANNELS  
The present invention relates to methods and compositions for modulating calcium channels. In particular, the present invention provides methods and compositions for modulating (e.g., disrupting)...
US20130252996 METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERS  
The invention features methods and kits employing bromolysergide in therapies for the treatment of cluster headache disorders.
US20130203798 DIAGNOSIS AND TREATMENT OF FUNCTIONAL DYSPEPSIA AND IRRITABLE BOWEL SYNDROME  
Methods for diagnosing, monitoring, and treating functional dyspepsia and/or irritable bowel syndrome, are disclosed comprising determining the presence of enterovirus in a gastrointestinal...
US20120282242 COMPOSITIONS, TARGETS, METHODS AND DEVICES FOR THE THERAPY OF OCULAR AND PERIOCULAR DISORDERS  
Methods for treating ocular and periocular disorders by administration to a human patient of a therapeutically effective amount of a compound that modulates muscle action.
US20070065463 Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions  
The invention is directed to topical formulations and methods of treating a migraines and/or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related...
US20150118327 COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING DISORDERS ASSOCIATED WITH CEPHALIC PAIN  
Compounds, e.g., of formula (I) and (Ia), pharmaceutical compositions comprising the compounds and methods of using the compounds and pharmaceutical compositions for treating pain disorders, e.g.,...
US20130090307 BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROLOGICAL DISORDERS  
The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid β toxicity. More specifically, the present...
US20110229570 ORALLY RAPIDLY DISINTEGRATING TABLET AND PROCESS FOR PRODUCING SAME  
Disclosed is an orally rapidly disintegrating tablet characterized in that the tablet can be produced in a conventional tablet manufacturing facility and has a satisfactory level of hardness for...
US20110237582 PYRIDO[3,4-B]INDOLES AND METHODS OF USE  
This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical compositions...
US20150024995 Combination Of Dopamine Agonists Plus First Phase Insulin Secretagogues For The Treatment Of Metabolic Disorders  
The present invention is directed to a method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the use of an agent(s) that increases central...
US20130116215 COMBINATION THERAPIES FOR TREATING NEUROLOGICAL DISORDERS  
The invention features novel pharmaceutical combinations useful for the treatment of neurological diseases, specifically neurodegenerative diseases. The novel pharmaceutical combinations of the...
US20130203762 VETERINARY ANTIPROLACTINIC COMPOSITION FOR RUMINANTS  
This present invention relates to an antiprolactinic veterinary composition to be administered to ruminants. Said composition comprises at least one antiprolactinic compound which is an agonist of...
US20140024670 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS  
The present invention relates to a veterinary anti-prolactin composition to be administered to ruminants. Said composition includes at least one anti-prolactin compound which is an agonist for...
US20140113927 TREATMENT UTILIZING HYDROPHOBIC WEAK BASES CHEMOTHERAPEUTIC AGENTS AND ILLUMINATION  
Hydrophobic weak base compounds such as hydrophobic weak base chemotherapeutic agents (which are not an anthracycline) for use in the treatment of medical conditions such as proliferative disease...
US20120283620 TREATMENT UTILIZING HYDROPHOBIC WEAK BASES CHEMOTHERAPEUTIC AGENTS AND ILLUMINATION  
Hydrophobic weak base compounds such as hydrophobic weak base chemotherapeutic agents (which are not an anthracycline) for use in the treatment of medical conditions such as proliferative disease...
US20150231123 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY CONTROLLING BLOOD GLUCOSE LEVEL  
The present invention relates to compositions and methods for controlling glycaemia in a mammalian in need thereof. The present invention relates to compositions and methods for the treatment of...
US20130123172 Treatment of Type 2 Diabetes With FTY720  
The present disclosure provides therapeutic methods for prevention and treatment of type-2 diabetes comprising administering to the subject an effective amount of FTY720 or an analog.
US20120108570 Pharmacological Treatment for Sleep Apnea  
The present invention relates generally to pharmacological methods for the prevention of amelioration of sleep-related breathing disorders via administration of agents or combinations of agents...
US20070225312 TERGURIDE / PROTERGURIDE FOR THE TREATMENT OF CHRONIC PAIN  
The present invention relates to the use of terguride and proterguride for the prophylaxis and/or the treatment of chronic pain conditions as well as to pharmaceutical compositions comprising...
US20070254906 Method of Administration of Dopamine Receptor Agonists  
Methods for treating a patient having pulmonary edema are described. The methods include administering to the lung endobronchial space of the airways of the patient an effective amount of a...
US20050032806 Method for treating anhedonia using dopamine agonists  
A method of treating anhedonia in a patient in need thereof, comprising administering to the patient an effective amount of a dopamine agonist
US20100189698 TREATMENT OR PROPHYLAXIS OF A NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS VIA OCULAR ADMINISTRATION  
A method for the treatment and/or prophylaxis of a neurological and/or neuropsychiatric disorder associated with altered dopamine function comprising administering to the eye of a patient in need...
US20140178449 METHODS FOR TREATING PARKINSON'S DISEASE  
Methods for restoring normal patterns of activity in a subject suffering from Parkinson's Disease are disclosed that include administering an effective steady state concentration of a dopamine...
US20110159066 Methods For Treating Parkinson's Disease  
Methods for restoring normal patterns of activity in a subject suffering from Parkinson's Disease are disclosed that include administering an effective steady state concentration of a dopamine...
US20100016280 Low Dosage Serotonin 5-HT2A Receptor Agonist To Suppress Inflammation  
Activation of 5-HT2A receptors using agonists at surprisingly low concentrations was shown to potently inhibit TNF-α-induced inflammation in multiple cell types. Significantly, proinflammatory...
US20150072939 LISURID, TERGURIDE AND DERIVATIVES THEREOF FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF FIBROTIC CHANGES  
The present invention relates to the use of 5-HT2 receptor antagonists and in particular of 8-α-ergolines such as lisuride, terguride and the derivatives thereof as 5-HT2B and 5-HT2A receptor...
US20140045879 Pharmaceutical Compositions for the Treatment of Capillary Arteriopathy  
The present invention relates to the use of ergot derivatives or ergolines, and in particular of lisuride and terguride for the prophylaxis and treatment of constrictive capillary arteriopathy....
US20080194522 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B)  
The present invention relates to compounds useful for detecting the activity of monoamine oxidases, compounds useful for competitively inhibiting monoamine oxidases, for determining inhibitors of...
US20110245261 ANTIPROLACTINIC VETERINARY COMPOSITION FOR RUMINANTS  
This present invention relates to an antiprolactinic veterinary composition to be administered to ruminants. Said composition comprises at least one antiprolactinic compound which is an agonist of...
US20130210803 FUSED TETRACYCLIC PYRIDO [4,3-B] INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE  
This disclosure is directed to fused tetracyclic pyrido[4,3-b]indoles and pyrido[3,4-b]indoles. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the...
US20150150833 Methods For Treatment of Parkinson's Disease  
New uses of safinamide, safinamide derivatives and MAO-B inhibitors in novel types of treatment for Parkinson's Disease are described. More specifically, the invention relates to methods for...
US20130053368 METHODS FOR TREATMENT OF PARKINSON'S DISEASE  
New uses of safinamide, safinamide derivatives and MAO-B inhibitors in novel types of treatment for Parkinson's Disease are described. More specifically, the invention relates to methods for...
US20080058318 MILNACIPRAN FOR THE TREATMENT OF COGNITIVE DYSFUNCTION ASSOCIATED WITH FIBROMYALGIA  
Methods for treating cognitive dysfunction associated with fibromyalgia by administering high-dose milnacipran to a patient suffering from such cognitive dysfunction are provided. Also provided...
US20140228355 Novel D3 Dopamine Receptor Agonists to Treat Dyskinesia in Parkinson's Disease  
The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering...
US20100160295 TREATMENT OF RESTLESS LEG SYNDROME AND SLEEP DISORDERS  
Methods of preventing and/or treating at least one symptom of Restless Leg Syndrome (RLS) and its related disorders, including disorders such as periodic limb movements in sleep (PLMS) and...
US20060205754 Combination of a serotonin reuptake inhibitors and agomelatine  
The present invention relates to the use of a combination of agomelatine and a serotonin reuptake inhibitor (SRIs), or an other compound, which causes an elevation in the level of extracellular...
US20130280323 Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture  
Disclosed herein is a soft elastic capsule that includes an acid resistant, capsule shell that defines an encapsulated space having a predetermined volume, a liquid or semisolid fill comprising a...
US20080166383 Antiallergic Latex or Pvc Products and the Method of Making Thereof  
The present invention provides an antiallergic latex or PVC product, which includes one or more natural antiallergic medicines selected from baicalin, matrine, liquorice saponin, tea polyphenol,...
US20140194435 NOVEL SUBSTITUTED INDOLO 4,3 FG QUINOLINES USEFUL FOR TREATING MIGRAINE  
Provided herein are novel ergoline derivatives and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of...
US20150031719 Topical Therapy for the Treatment of Migraines, Muscle Sprains, Muscle Spasms, Spasticity and Related Conditions  
The invention is directed to topical formulations and methods of treating a migraines and/or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related...
US20130225558 FUSED TETRACYCLIC PYRIDO [4,3-B] INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE  
This disclosure is directed to fused tetracyclic pyrido[4,3-b>]indole and pyrido[3,4-b]indole derivatives. Pharmaceutical compositions comprising the compounds are also provided, as are methods of...
US20120114741 TOPICAL THERAPY FOR THE TREATMENT OF MIGRANES, MUSCLE SPRAINS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS  
The invention is directed to topical formulations and methods of treating a migraines and/or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related...
US20060281752 Method for the normalization of sexual response and amelioration of long term genital tissue degradation  
The present invention provides, in one embodiment, a method of normalizing the timing of sexual response in a mammal comprising the administration of an amount of a central nervous system sexual...
US20150148371 NOVEL NEUROMODULATORY COMPOUNDS  
Provided herein are novel neuromodulatory compounds and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical...
US20130165469 NOVEL NEUROMODULATORY COMPOUNDS  
Provided herein are novel neuromodulatory compounds and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical...
US20080108642 Composition and its use as effective constituent of a medicine having anti-angiogenesis synergy effect  
The present invention relates to a composition as effective constituent of a medicine having anti-angiogenesis synergy effect and belongs to the field of medicine compositions. The recipe is...
US20140051717 METHODS AND SYSTEMS FOR TREATMENT OF MIGRAINES AND OTHER INDICATIONS  
The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use of a hostile biophysical environment....

Matches 1 - 50 out of 141 1 2 3 >